Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Kempton

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Thrombosis and Haemostasis : JTH|August 14, 2010
In non-severe hemophilia A the risk of inhibitor after intensive factor treatment is greater in older patients: a case-control studyC L Kempton, J M Soucie, C H Miller, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 23, 2013
A study of prospective surveillance for inhibitors among persons with haemophilia in the United StatesJ M Soucie, C H Miller, F M Kelly, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 20, 2012
Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia AC L Kempton, T C Abshire, R A Deveras, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 19, 2017
Self-reported prevalence, description and management of pain in adults with haemophilia: methods, demographics and results from the Pain, Functional Impairment, and Quality of life (P-FiQ) studyM Witkop, A Neff, T W Buckner, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 17, 2015
Distress in patients with bleeding disorders: a single institutional cross-sectional studyV Barry, M E Lynch, D Q Tran, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 24, 2017
Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patientsP W Collins, D V K Quon, M Makris, et al.
Journal of Thrombosis and Haemostasis : JTH|August 25, 2017
Effect of late prophylaxis in hemophilia on joint status: a randomized trialM J Manco-Johnson, B Lundin, S Funk, et al.
Journal of Thrombosis and Haemostasis : JTH|September 19, 2015
Inhibitor recurrence after immune tolerance induction: a multicenter retrospective cohort studyA Antun, P E Monahan, M J Manco-Johnson, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Thrombosis and Haemostasis : JTH|August 14, 2010
In non-severe hemophilia A the risk of inhibitor after intensive factor treatment is greater in older patients: a case-control studyC L Kempton, J M Soucie, C H Miller, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 23, 2013
A study of prospective surveillance for inhibitors among persons with haemophilia in the United StatesJ M Soucie, C H Miller, F M Kelly, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 20, 2012
Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia AC L Kempton, T C Abshire, R A Deveras, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 19, 2017
Self-reported prevalence, description and management of pain in adults with haemophilia: methods, demographics and results from the Pain, Functional Impairment, and Quality of life (P-FiQ) studyM Witkop, A Neff, T W Buckner, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 17, 2015
Distress in patients with bleeding disorders: a single institutional cross-sectional studyV Barry, M E Lynch, D Q Tran, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 24, 2017
Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patientsP W Collins, D V K Quon, M Makris, et al.
Journal of Thrombosis and Haemostasis : JTH|August 25, 2017
Effect of late prophylaxis in hemophilia on joint status: a randomized trialM J Manco-Johnson, B Lundin, S Funk, et al.
Journal of Thrombosis and Haemostasis : JTH|September 19, 2015
Inhibitor recurrence after immune tolerance induction: a multicenter retrospective cohort studyA Antun, P E Monahan, M J Manco-Johnson, et al.
Pageof 3